A neutral platform for the UAE clinical research ecosystem.
The UAE Clinical Research Roundtables convene senior decision-makers to discuss, share perspectives and drive meaningful change — one focused theme at a time.
Advance clinical research excellence in the UAE through open dialogue, collaboration and collective action.
Multi-stakeholder collaboration
Bringing together the entire ecosystem for collective impact.
Open dialogue & trust
Creating a safe space for honest conversations.
Actionable insights & solutions
Turning shared insights into practical progress.
Shared commitment to impact
Uniting around a common goal: better research, better outcomes.
What is the Clinical Research Roundtable?
The UAE Clinical Research Roundtables bring senior decision-makers together four times a year to advance the country's clinical research ecosystem — one focused theme at a time. They are designed to support the ecosystem broadly, including government priorities, not only industry needs.
Curated
Invite-only, private working-session dinners with senior leaders across the ecosystem.
Thematic
Each roundtable focuses on strategic themes with actionable discussion topics.
Cumulative
Outputs inform regulators, translate into actions, and achievements are shared at the annual flagship event.
The 08+ groups we convene from.
Each roundtable is curated around its theme — the room flexes with the problem being discussed, so not every group is at every table.
Invitees are senior representatives of their organisations, bringing institutional context and personal expertise to the discussion.
- 01RegulatorsEDE, DoH, DHA, MoHAP
- 02Hospitals & health systemsPublic and private
- 03AcademiaUniversities & research centres
- 04Industry sponsorsPharma & biotech
- 05CROs & service providersOperational backbone
- 06InvestorsVC, sovereign, corporate
- 07Government & policyNational & emirate-level
- 08Patient associationsAdvocacy & community voice
A clear model — independent by design.
- 01Annual agenda
The CRR-UAE Founding Members independently curate the year's themes and each Roundtable agenda.
- 02Theme-led curation
Each roundtable is built around a specific theme. The room flexes with the topic, so only the most relevant stakeholders are invited.
- 03Per-seat participation
Senior representatives are selected according to the expertise and perspectives needed for each discussion.
- 04Independent execution
Participation and partnership never confer control over agendas, participant composition or outcomes.
Why this matters — and why now.
The UAE has world-class hospitals, an ambitious life-sciences agenda, and regulators actively modernising. But there's still work to do to connect the ecosystem, attract sponsors and champion clinical research in the UAE.
- Regulatory momentum
- UAE regulators are actively signalling openness to faster, more modern approval pathways. The window to help shape that framework is now.
- Hospital readiness
- Major UAE centres are building world-class research capacity — and shaping what 'trial-ready' looks like for the region.
- Sponsor demand
- Global sponsors are actively seeking Middle East data and more diverse trial populations — the UAE is positioned to deliver both.
- Strategic alignment
- From UAE Vision 2031 to the national innovation and life-sciences agenda, the country's strategy, capital and infrastructure are pulling in one direction: clinical research as a national priority.